Gender-affirming medical treatment is essential healthcare, not special treatment. The NHS, the World Health Organisation, and the Royal College of Psychiatrists all recognise gender dysphoria as a serious condition for which treatment is clinically indicated. Withholding care causes measurable harm. Providing it saves lives.
Where does the "special treatment" claim come from?
I hear this framing regularly, and it is worth naming what it actually is. When people describe gender-affirming care as "special treatment," they are not making a clinical argument. They are making a political one. The claim is that trans people are receiving something they have not earned, something extra, something unfair. It positions trans healthcare not as treatment for a recognised medical condition but as a preference or a lifestyle choice being indulged at public expense.
That framing is false, and it is harmful. Every major medical body that has examined the evidence has reached the same conclusion: gender dysphoria is a serious condition, and treatment for it is clinically indicated. This is not a fringe position. It is the consensus of the organisations that set the standards for medicine globally.
What the major medical bodies actually say
The NHS recognises gender dysphoria and provides treatment for it within its services, including referrals for hormone therapy and surgery. The World Health Organisation classifies gender incongruence in its International Classification of Diseases. The Royal College of Psychiatrists has published position statements supporting gender-affirming care. The Endocrine Society has published detailed clinical practice guidelines on gender-affirming hormone therapy. WPATH, whose Standards of Care are now in their eighth edition, sets out the international framework for assessment and treatment.
These are not advocacy organisations. They are the bodies that govern medicine. When they say treatment is clinically indicated, that means doctors are expected to provide it, that withholding it requires justification, and that a patient who needs it and does not receive it has been failed.
So the question is not whether gender-affirming care is a legitimate medical treatment. That question is settled. The question is why the "special treatment" framing persists despite the evidence, and who it serves.
What "clinically indicated" actually means
Clinically indicated means that the treatment improves outcomes. For gender-affirming care, the outcomes are documented and they are significant. People who receive gender-affirming treatment report substantially better mental health, lower rates of depression and anxiety, lower rates of suicidal ideation, and better quality of life. People who seek treatment and do not receive it, or who face long delays, show measurably worse outcomes on every one of those measures.
This is not complicated. When a treatment reliably improves outcomes and withholding it reliably worsens them, it is essential. The word "essential" is not rhetorical here. It is the clinical description of what this care does for the people who need it.
I spent years listening to people describe what it felt like to have a recognised need and be told that need was not real, not urgent, or not worth the public resource. The harm from that dismissal was not abstract. It was measurable in the lives of real people. And that harm was caused not by some unavoidable side effect of treatment but by the decision to withhold it.
Is leave to access treatment "unfair"?
A version of the "special treatment" argument focuses not on the care itself but on the accommodations people need to access it. The claim is that allowing someone time off for gender-affirming appointments, or supporting them through a transition at work or in education, amounts to unfair advantage.
This does not hold up. No one describes a person with diabetes as receiving special treatment because they need time for insulin management. No one calls it unfair that someone receiving cancer treatment takes leave for appointments. The principle that people with medical needs receive support to access treatment is not controversial when applied to any other condition. The controversy appears specifically and only when the condition is gender dysphoria, which tells you that the controversy is not really about the principle at all.
In the UK, the Equality Act 2010 protects trans people through the characteristic of gender reassignment. Employers and service providers are required to make reasonable adjustments. This is not a gift. It is a legal right that exists precisely because the law recognises that trans people face barriers that others do not, and that removing those barriers is a matter of equality, not preference.
The cost of calling essential care "optional"
When gender-affirming care is framed as optional, non-essential, or preferential, the consequences are real. Funding gets cut. Waiting lists grow. Gatekeeping intensifies. Young people in particular face a clock that does not pause while processes drag on. Puberty does not wait for an argument to be resolved. Every month of an unwanted puberty is a permanent physical change that treatment later cannot fully undo.
I am not describing a theoretical risk. I have heard from many people who spent years navigating systems that treated their care as a low priority because the cultural framing had made it seem discretionary. The harm accumulated quietly, without headlines, across thousands of individual lives.
Delay is not neutral. It is a decision. And describing essential care as optional is one of the ways that decision gets made without being named as a decision at all.
What "special treatment" gets backwards
Here is what strikes me most about this framing. Trans people are not asking for more than anyone else. They are asking for the same thing: treatment for a recognised condition, delivered by qualified practitioners, in a reasonable timeframe, with the same respect afforded to every other patient.
In most places, they are not getting that. Waiting lists for NHS gender services run to years. The private landscape is expensive and inconsistently regulated. Puberty blockers have been severely restricted in the UK, with consequences that have fallen hardest on young people who had no other options. If anything, trans people are receiving less than the standard of care that everyone else is entitled to expect, while simultaneously being told they are receiving too much.
That is not a coincidence. The "special treatment" framing does ideological work. It creates the impression of unfairness in a direction that serves the argument for restriction, and it does so by ignoring the actual evidence about what this care is, what it does, and what happens when it is withheld.
The settled question and the real one
Gender-affirming care is essential healthcare. That question is settled by the consensus of every major medical body that has examined it. The real question is how we ensure that the people who need it can actually access it, without years of delay, without gatekeeping that would be considered unacceptable for any other condition, and without having to spend their energy arguing that their medical need is real.
That is the conversation worth having. Not whether trans people deserve care, but how we build systems that deliver it with the same seriousness and the same respect we bring to everything else in medicine.
If there is a topic that you would like me to cover, just let Sammy know.
Dr Helen Webberley is a gender specialist, medical educator, and advocate. She is the founder of GenderGP and writes about trans healthcare, rights, and the lives of trans people and their families.
Comments